Invention Grant
- Patent Title: Active principle for mitigating undesired medical conditions
-
Application No.: US15053645Application Date: 2016-02-25
-
Publication No.: US09962451B2Publication Date: 2018-05-08
- Inventor: Tim Bowden , Kristoffer Bergman , Thomas Engstrand , Lennart Soderberg
- Applicant: PVAC MEDICAL TECHNOLOGIES LTD
- Applicant Address: CY Nicosia
- Assignee: PVAC MEDICAL TECHNOLOGIES LTD.
- Current Assignee: PVAC MEDICAL TECHNOLOGIES LTD.
- Current Assignee Address: CY Nicosia
- Agency: Young & Thompson
- Priority: SE1100066 20110131
- Main IPC: A61K31/765
- IPC: A61K31/765 ; A61K47/48 ; A61K31/785 ; A61K31/787

Abstract:
A composition for treating or preventing inflammatory-related conditions includes as an active principle a carrier which exhibits a plurality of a scavenger structure capable of mitigating the activity of a mediator of inflammatory-related conditions. The scavenger structure includes a nucleophilic center complying with the formula X1(—R″—)(—R′)mHn where: a) X1 is a single-bonded heteroatom selected amongst N, O and S and exhibits a free electron pair; b) m is 0 or 1 and n is 1 or 2; c) —R″— is a bivalent organic group providing attachment to the carrier via one of its free valences and to X1 at the other free valence; and d) R′— is a monovalent organic group attached to the X1 via its free valence. A method for treating or preventing inflammatory-related conditions in an individual suffering from such conditions includes: providing the composition; and contacting the mediator within or separate from the individual.
Public/Granted literature
- US20160175451A1 ACTIVE PRINCIPLE FOR MITIGATING UNDESIRED MEDICAL CONDITIONS Public/Granted day:2016-06-23
Information query